A5102914256- Cardiac Valve Diseases and Treatments
- Cardiac and Coronary Surgery Techniques
- Infective Endocarditis Diagnosis and Management
- Cardiac, Anesthesia and Surgical Outcomes
- Coronary Interventions and Diagnostics
- Orthopedic Infections and Treatments
- Orthopaedic implants and arthroplasty
- Total Knee Arthroplasty Outcomes
- Cardiac pacing and defibrillation studies
- Pleural and Pulmonary Diseases
- Atrial Fibrillation Management and Outcomes
- Bacterial Infections and Vaccines
- Cardiovascular Function and Risk Factors
- Urologic and reproductive health conditions
- Cardiac Arrhythmias and Treatments
- Intensive Care Unit Cognitive Disorders
- Cardiac Imaging and Diagnostics
- Cardiovascular and Diving-Related Complications
- Cardiac Structural Anomalies and Repair
- Aortic aneurysm repair treatments
- Trauma Management and Diagnosis
- Urinary and Genital Oncology Studies
- Airway Management and Intubation Techniques
Onze Lieve Vrouwziekenhuis Hospital
2004-2024
Sapienza University of Rome
2024
Semmelweis University
2024
KU Leuven
2019
University Surgical Associates
2006
Minimally invasive access has become the preferred choice in mitral and/or tricuspid valve surgery. Reported outcomes are at least similar to classic sternotomy although aortic cross-clamp times usually longer.We analysed largest registry of surgery patients (mini-mitral international (MMIR)) for relationship between times, mortality and other outcomes. From 2015 2021, 7513 consecutive underwent mini-mitral 17 Heart-Valve-Centres. Data were collected according Mitral Valve Academic Research...
Background— Robotic totally endoscopic coronary artery bypass (TECAB) of the left anterior descending (LAD) coupled with percutaneous intervention (PCI) a second has been investigated in patients multivessel disease to provide minimally invasive therapeutic option. Methods and Results— TECAB LAD was performed using internal mammary (LIMA). A lesion treated PCI before surgery, simultaneously, or after surgery. Three-month angiographic follow-up all subject independent review. total 27...
Abstract OBJECTIVES With the popularization of catheter-based mitral valve procedures, evaluating risk-specific differentiated clinical outcomes after contemporary surgery is crucial. In this study, we assessed operative results minimally invasive operations across different patient risk profiles and evaluated value EuroSCORE (ES) II predicted mortality model for prediction, in large cohort Mini-Mitral International Registry (MMIR). METHODS The MMIR database was used to analyse mini-mitral...
We aimed to assess the impact of complex mitral valve disease and patient risk profile on operative outcomes in large cohort Mini-Mitral International Registry.
ObjectiveRandomized evidence suggests a high risk of pacemaker implantation for patients undergoing mitral valve (MV) surgery with concomitant tricuspid repair (cTVR). We investigated the impact cTVR on outcomes in Mini-Mitral International Registry.MethodsFrom 2015 to 2021, 7513 underwent minimally invasive MV or without 17 international centers (MV: n = 5609, cTVR: 1113). Propensity matching generated 1110 well-balanced pairs. Multivariable analysis was applied.ResultsPatients were older...
The aim of this study was to examine the incidence and predictors stroke after minimally invasive mitral valve surgery (mini-MVS) assess role preoperative CT scan on surgical management neurological outcomes in large cohort Mini-Mitral International Registry.Clinical, operative in-hospital patients undergoing mini-MVS between 2015 2021 were collected. Univariable multivariable analyses used identify stroke. Finally, impact assessed.Data from 7343 1.3% (n = 95/7343). Stroke associated with...
De Cooman, S.; Foubert, L.; Van Praet, F.*; Ruyter, E.; Nollet, G.; Deloof, T. Author Information
A 62-year-old man presents to the Cardiology Department with a two years history of angina on exertion. Invasive coronary angiography revealed severe three vessels artery disease. The “Hybrid Heart Team” successfully performed fully robotically-assisted hybrid revascularization combining RE-MIDCAB LAD and R-PCI non-LAD lesions.